Parataxation Holdings' backdoor listing in South Korea, with Bitcoin as its core reserve

BlockBeats News: On June 20th, according to the US news agency, Parataxis Holdings LLC, an investment company focused on the digital asset field, is an affiliate of Parataxis Capital Management LLC. Through Parataxi Korea Fund I LLC and its affiliates, Parataxi Holdings has signed a final agreement with Bridge Biotherapeutics, Inc., a biotechnology company, to invest KRW 25 billion in order to acquire a controlling stake in the company (the "Transaction"). After the transaction is completed, the company plans to change its company name to Parataxi Korea and continue to be listed on KOSDAQ. This transaction still needs to meet the customary closing conditions, including shareholder approval. This transaction will lead to the birth of a Bitcoin based reserve platform in the South Korean public market, backed by institutional investors with rich experience in digital asset investment. As part of this transaction, Edward Chin, founder and CEO of Parataxi Holdings and co-founder and CEO of Parataxi Capital, will join the company's board of directors. Parataxis Capital partner Andrew Kim will serve as the company's CEO and also join the board of directors. James Jungkue Lee, co-founder of Bridge Bio, will continue to lead the company's core biotechnology business and retain a seat on the board of directors.